Novel InMOI Index Flags Renal Impairment in New T2DM Cases Tags Diabetic Nephropathy Read more about Novel InMOI Index Flags Renal Impairment in New T2DM Cases
Bariatric Surgery vs Semaglutide Shows Mixed MASLD Outcomes in T2DM Tags GLP-1 agonists Read more about Bariatric Surgery vs Semaglutide Shows Mixed MASLD Outcomes in T2DM
Semaglutide Shows No Link to Lower Cirrhosis or HCC Risk Tags GLP-1 agonists Read more about Semaglutide Shows No Link to Lower Cirrhosis or HCC Risk
SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria
Pregabalin Dose Matters for Pain Relief in Diabetic Neuropathy Tags Diabetic Neuropathy Read more about Pregabalin Dose Matters for Pain Relief in Diabetic Neuropathy
GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM Tags Sulphonylureas GLP-1 agonists DPP-4 inhibitors Thiazolidinediones Read more about GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM
Higher SBP on ABPM Marks Carotid Plaque Risk in T2DM Tags hBA1c Read more about Higher SBP on ABPM Marks Carotid Plaque Risk in T2DM
AKI in T2DM Shows Lower TIR and Higher Hyperglycemia Burden Tags Hypoglycemia Read more about AKI in T2DM Shows Lower TIR and Higher Hyperglycemia Burden
Multi-Omics Model Improves T2DM Risk Stratification Accuracy Read more about Multi-Omics Model Improves T2DM Risk Stratification Accuracy
TyG Index Shows Stronger Signal for Early DKD in T2DM Tags Diabetic Nephropathy Read more about TyG Index Shows Stronger Signal for Early DKD in T2DM